This invention belongs to the field of
biomedicine, specifically relating to a strain of
Bifidobacterium bifidum and its application in
eye health products. The
Bifidobacterium bifidum (…
Bifidobacterium bifidum
Bifidobacterium bifidum BB00, with accession number CGMCC No. 34389, is a product of this invention. It can improve the clinical symptoms of dry eye syndrome, increase
tear secretion, prolong tear film
breakup time, reduce
ocular surface disease index, alleviate corneal epithelial damage, and regulate palpebral
fissure opening. It can also regulate the composition of the intestinal
flora, increase
flora diversity, and inhibit the growth of pathogenic
intestinal bacteria.
Bifidobacterium bifidum BB00 not only provides an innovative solution to the clinical pain point of dry eye syndrome, achieving synergistic intervention between intestinal regulation and
eye health, but also possesses scientific innovation,
clinical effectiveness, and industrialization potential. It has significant value for the application of
bacteria and bacterial agents in the biomedical field and for the treatment of
ocular surface-intestinal related diseases.